Drugwatch works with medical and legal experts to provide quality, accurate information about prescription drug side effects, medical device complications and related lawsuits. Our team members have several years of medical and legal research experience and are passionate about advocating for people injured by the negligence of corporations. Through Drugwatch, consumers can get the information they need to make informed health care decisions, share their drug and device stories, and connect with an experienced national law firm.
To keep people safe from potentially harmful drugs, medical devices and procedures by informing them of medical conditions, severe side effects and ways to take action.
Drugwatch is a trusted consumer advocacy organization that works side by side with medical and legal experts to educate the public on dangerous drugs and medical devices and to empower consumers to assert their legal rights.
Our headquarters is in Orlando, Florida, where we produce Drugwatch.com.
Drugwatch.com is the go-to resource for information about the prescription drugs you take, the medical devices you’re implanted with, the conditions and procedures you’ve endured, and the legal options that may be available.
Our team of writers sifts through complex medical journals, court records and government documents to provide you with important information in language you can understand. We give patients a platform to share their stories and the resources they need to take action against negligent companies.
Drugwatch is funded by its sponsors, mass tort law firms Weitz & Luxenburg P.C. and Simmons Hanly Conroy LLC. Our sponsors do not control the content on Drugwatch.com. Instead, they give Drugwatch the freedom to provide valuable information for free and connect people with some of the top lawyers in the country.
Drugwatch has been a trusted resource for consumers since 2009. Our website is a HONCode (Health On the Net Foundation) certified site, which means we provide high-quality health information from credible sources, such as peer-reviewed medical journals. Our content comes directly from or is reviewed by medical and legal experts to ensure its accuracy and thoroughness.
Drugwatch holds an A+ rating with the Better Business Bureau.
The BBB determines ratings based on trust and reliability factors, including a company’s interactions with consumers, customer reviews, licensing, and ethical advertising practices. Drugwatch strives to uphold the highest standards of accuracy and quality of information while advocating for people who have been affected by dangerous drugs and medical devices.
Drugwatch’s expert writers and outreach team draw on their research skills, relationships with experts and personal experiences to provide information and spread awareness. They have the expertise to find high-quality information from medical journals, court documents and specialists in the field. Our writers all completed health literacy training from the Centers of Disease Control and Prevention and hold memberships with professional organizations including the American Medical Writers Association, American Bar Association (associate), The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.
Drugwatch’s expert contributors are medical and legal professionals who work with Drugwatch to provide content, share their insight and review the information on Drugwatch.com for accuracy and quality. The experts provide a wealth of knowledge through videos, articles and podcasts. Drugwatch takes the time to make sure each expert is highly qualified and committed to Drugwatch’s mission to keep the public safe from risky drugs and medical devices. Drugwatch also partners with Physicians’ Review Network Inc., a nationally recognized leader in providing independent medical reviews through its network of specialists.
Drugwatch.com is funded by top law firms in mass tort litigation.
All Drugwatch services are free. There is no requirement for anyone to be a client of its sponsors to receive assistance from the Drugwatch team.
When Drugwatch visitors call a phone number on the website or fill out a free case review form, a Drugwatch representative will connect them with the appropriate legal professional.
Drugwatch adheres to a strict code of integrity, accuracy and quality in producing all the content on our website. Our sources include peer-reviewed medical journals, reputable news outlets, court documents, U.S. Food and Drug Administration reports, patients with first-hand experience and experts in the medical and legal fields. We are committed to being transparent about content, so we provide a list of sources on each page as well as contact information for the editor, reviewer and authors. It is our intention for every page on Drugwatch to be medically or legally reviewed by credible experts to ensure the information you get from us is factual, complete and of the highest quality.
Drugwatch supports organizations that advocate for patients. We also serve as a watchdog on behalf of consumers, and we give patients a voice.
Our investigative feature stories explore topics important to consumers, including the FDA’s approval process, the high prices of drugs, Big Pharma marketing and issues in women’s health. These features educate the public and expose corporate practices that could endanger consumers or hurt their wallets. These stories also provide links to petitions and ways to take action.
Drugwatch’s Beyond the Side Effects section gives patients an opportunity to be heard. It highlights ways their lives changed because of serious side effects or complications from drugs and medical devices. Anyone seriously harmed by medical products may share a story with Drugwatch for possible publication on our website.
Drugwatch helps journalists who are reporting on prescription drugs and medical devices. We provide expert quotes, medical research, legal information and insight into the FDA, Big Pharma, and dangerous side effects and complications. We also write guest content and op-ed pieces at no charge.
If you would like to learn more about our work or need content for news in your area, please reach out to us. We are happy to work with you.
A New York Times op-ed attacked the lack of research on medical devices before FDA approval. Instead, manufacturers rely on tests after marketing devices. It said that the agency considered allowing even less upfront research.Read Article
The Lancet medical journal published a study on the complications women suffered following mesh and non-mesh surgeries. The study found an increased risk of later complications with certain mesh techniques.Read Article
The Huffington Post cautions against mixing pain relievers with alcohol. The article highlights major pain relievers including Tylenol, Advil, Motrin and Excedrin. Each pain reliever has its own adverse reactions when taken with alcohol.Read Article
A Washington Examiner opinion sought transparency in medical device complaints to the FDA. Public databases of device problems are difficult to search. People may not be able to find out about risks.Read Article
Healthline reported on a recent pharma-funded study that concluded the appetite suppressant lorcaserin did not increase the risk of serious heart problems. However, questions still remain.Read Article
STAT News reported that the FDA’s records of patient injuries linked to drugs and devices are inaccurate. According to the article, inconsistent side effects and complications reports by drug makers are to blame.Read Article
BuzzFeed News reported on the devastating complications of surgical mesh for women in Australia. Women in the article describe how the medical device ruined their lives and what they are doing to spread awareness.Read Article
This article on Dr. Axe discusses natural ways to treat cystic acne — a severe form of acne. It also highlights the side effects linked to Accutane (isotretinoin), including birth defects, Crohn’s disease and suicide.Read Article
Substance Abuse and Mental Health Services Administration (SAMHSA) sponsors Recovery Month. SAMHSA spreads awareness about mental disorders and recovery. It listed Drugwatch in its directory of helpful organizations.Read Article
Drugwatch Expert Contributor E. Scott Sills, MD, PhD, edited an academic book on Essure permanent birth control featuring studies, legal opinions and the account of a woman injured by the device. Nova, the book’s publisher, published our book review.Read Article
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's sponsors support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.(888) 645-1617